Uterine Artery Embolization: Non-Surgical Treatment for Fibroids

What is Uterine Artery Embolization?

Uterine artery embolization is a minimally invasive procedure that treats symptomatic uterine fibroids without surgery. The technique involves threading a thin catheter through blood vessels to reach the arteries that feed the fibroids. Interventional radiologists then release tiny particles that block blood flow to the fibroids, causing them to shrink over time. This uterus-sparing treatment effectively reduces heavy menstrual bleeding, pelvic pain, and pressure symptoms. The outpatient procedure typically takes one to two hours and allows most women to return home the same day with significantly faster recovery than traditional surgical options.

Understanding Uterine Artery Embolization and How It Works

Uterine artery embolization, also known as UFE (uterine fibroid embolization), blocks the blood supply to fibroids causing them to shrink and die.

Fibroids are benign tumors that grow in the uterine wall, often causing heavy bleeding, pain, and pressure on surrounding organs. These common conditions affect up to 80 percent of women by age 50. While fibroids aren’t cancerous, their symptoms significantly impact quality of life for many women.

The UAE procedure uses selective catheter-based techniques to target only the arteries feeding fibroids while preserving normal uterine tissue. Dr. Samir Abdel Ghaffar, a consultant interventional radiologist with practices in London and Cairo, specializes in this precise treatment approach. His expertise in interventional radiology allows him to treat fibroids and adenomyosis through minimally invasive catheterization rather than traditional surgery.

How uterine artery embolization differs from surgery:

• No general anesthesia required—conscious sedation suffices
• Tiny puncture instead of surgical incisions
• Preserves the uterus, maintaining fertility options
• Recovery measured in days rather than weeks
• Treats all fibroids simultaneously in one session
• Lower complication rates compared to surgical alternatives

Clinical evidence demonstrates that UAE effectively reduces fibroid symptoms in 85 to 90 percent of patients. The treatment works by permanently blocking the blood vessels that nourish fibroids, causing them to shrink by 40 to 60 percent over the following months.

The Uterine Artery Embolization Procedure Step by Step

The UAE procedure follows a systematic approach performed in a specialized interventional radiology suite.

Preparation Phase

Before the procedure, your interventional radiologist reviews imaging studies—typically ultrasound or MRI—to map fibroid locations and sizes. You receive mild sedation to keep you comfortable but awake. The team monitors your vital signs throughout. A local anesthetic numbs the small access site, usually in your groin or wrist.

Catheter Navigation

Your doctor makes a tiny puncture and threads a catheter through your arterial system. Using real-time X-ray guidance, they navigate the catheter to each uterine artery. This precise technique requires specialized training in interventional radiology and vascular anatomy. The catheter positioning takes the most time during the procedure.

Embolization Process

Once positioned correctly, your doctor injects tiny particles—typically between 500 and 900 microns in size—through the catheter. These embolic particles flow downstream and lodge in the small vessels feeding your fibroids. The particles permanently block blood flow to the fibroid tissue while sparing normal uterine muscle. Both uterine arteries receive treatment during the same session.

Immediate Recovery

After completing the embolization, your doctor removes the catheter and applies pressure to seal the puncture site. You move to a recovery area where medical staff monitor you for several hours. Most women experience cramping as fibroids begin shrinking—this is normal and managed with pain medication. The entire procedure typically takes one to two hours from start to finish.

Medical Uses of UAE Beyond Fibroid Treatment

While uterine artery embolization gained recognition for treating symptomatic uterine fibroids, the technique effectively addresses several other gynecological conditions.

Adenomyosis Treatment

Adenomyosis occurs when uterine lining tissue grows into the muscular uterine wall, causing severe menstrual pain and heavy bleeding. UAE reduces adenomyosis symptoms by decreasing blood supply to affected areas. Women with adenomyosis often experience significant relief from cramping and bleeding after embolization. Studies suggest that UAE improves quality of life for 70 to 75 percent of adenomyosis patients.

Postpartum Hemorrhage Control

UAE provides life-saving treatment for severe bleeding after childbirth when other methods fail. Postpartum hemorrhage represents a medical emergency requiring rapid intervention. Embolization can stop hemorrhage while preserving the uterus and future fertility. This application has become increasingly common in obstetric emergencies, particularly after cesarean deliveries or retained placenta.

Other Medical Applications

• Abnormal uterine bleeding: When bleeding has no identifiable cause
• Pelvic congestion syndrome: Chronic pelvic pain from dilated veins
• Vascular malformations: Abnormal blood vessel connections in the pelvis
• Placenta accreta prevention: Reducing bleeding risk in high-risk pregnancies

The use of UAE continues expanding as interventional radiologists develop refined techniques. Dr. Samir Abdel Ghaffar applies these advanced methods to treat various gynecological conditions through catheterization, offering women alternatives to invasive surgery.

Uterine Artery Embolization Success Rates and Outcomes

Long-term outcomes from uterine artery embolization demonstrate high effectiveness with symptom improvement lasting years for most patients.

Immediate and short-term results:

• Fibroids begin shrinking within weeks of treatment
• Maximum fibroid reduction occurs at 3 to 6 months post-procedure
• Heavy menstrual bleeding improves in 85 to 90 percent of women
• Pelvic pain and pressure symptoms decrease significantly
• Most women return to normal activities within one to two weeks

Long-term effectiveness:

Clinical experience shows that symptom relief persists for years after UAE. Research following patients for five years documents continued improvement in quality of life. Approximately 10 to 15 percent of women require additional treatment within five years, either repeat UAE or surgical intervention. This reintervention rate compares favorably to myomectomy, where fibroids commonly regrow.

Factors influencing outcomes:

• Fibroid size and number: Multiple smaller fibroids respond as well as single large ones
• Fibroid location: Submucosal fibroids (inside uterine cavity) may pass after treatment
• Patient age: Women approaching menopause often see complete symptom resolution
• Technical success: Complete embolization of all feeding vessels improves results

Interventional radiologists report high patient satisfaction following UAE. Women appreciate avoiding major surgery, preserving their uterus, and achieving symptom relief without prolonged recovery periods.

UAE Compared to Hysterectomy and Myomectomy

Choosing between UAE, hysterectomy, and myomectomy depends on individual circumstances, fertility goals, and symptom severity.

UAE versus Hysterectomy

Hysterectomy surgically removes the entire uterus, permanently eliminating fibroids and bleeding. This definitive solution works for women who have completed childbearing and accept losing their uterus. However, hysterectomy requires general anesthesia, hospital admission, and recovery lasting four to six weeks. Surgical complications include bleeding, infection, and injury to nearby organs.

UAE offers comparable symptom relief while preserving the uterus. The minimally invasive nature means faster recovery, fewer complications, and maintained reproductive anatomy. Women who value uterus preservation strongly prefer UAE over hysterectomy when both options exist.

UAE versus Myomectomy

Myomectomy surgically removes individual fibroids while leaving the uterus intact. This option suits women actively trying to conceive, as it preserves normal uterine architecture. However, myomectomy requires significant surgery with general anesthesia and recovery time. Fibroids frequently regrow after myomectomy—up to 50 percent of women develop new fibroids within five years.

UAE treats all fibroids simultaneously without cutting into the uterus. The procedure works regardless of fibroid number or location within the uterine wall. Recovery is substantially faster than myomectomy. The main consideration involves fertility—discussed further in dedicated sections below.

Comparative advantages of UAE:

• Treats multiple fibroids in one session without multiple incisions
• Lower blood loss and transfusion requirements
• Shorter hospital stay—often same-day discharge
• Reduced surgical complications
• No visible scarring
• Returns to normal activity within one to two weeks

The optimal treatment depends on your specific situation. Dr. Samir Abdel Ghaffar provides comprehensive consultation to help women understand their options and make informed decisions aligned with their goals and medical needs.

Recovery After Uterine Artery Embolization

Recovery from UAE progresses through predictable stages with most women returning to normal activities relatively quickly.

First 24 Hours

Immediately after the procedure, you rest in a recovery area for several hours while medical staff monitor your vital signs. Cramping typically begins as fibroids start dying from lack of blood supply. Pain medication manages this discomfort effectively. Some women experience nausea, low-grade fever, or fatigue—all normal responses. Most patients go home the same day, though overnight observation occasionally occurs.

First Week

The first few days involve managing post-embolization syndrome—cramping, mild fever, fatigue, and general malaise. These symptoms reflect your body’s response to fibroid death. Pain medication, rest, and hydration help you through this period. Light activities are acceptable, but avoid strenuous exercise. The puncture site heals quickly with minimal care. Many women take one week off work for recovery.

Weeks 2 Through 4

Energy levels improve steadily during this phase. Cramping and discomfort diminish significantly. Most women return to work and resume normal daily activities. Some vaginal discharge occurs as fibroid tissue breaks down—this is expected. Avoid tampons, douching, and sexual intercourse for approximately two weeks after the procedure to reduce infection risk.

Long-term Recovery

By one month post-procedure, most women feel completely recovered. Fibroids continue shrinking over the following three to six months. Heavy bleeding typically improves with your next menstrual cycle. Pelvic pressure symptoms decrease as fibroids shrink. Follow-up imaging at three to six months documents fibroid size reduction and treatment success.

Recovery tips for optimal outcomes:

• Take prescribed pain medication on schedule
• Stay well hydrated to help flush out dead tissue
• Walk gently to prevent blood clots
• Avoid lifting heavy objects for two weeks
• Contact your doctor for severe pain, heavy bleeding, or fever above 101°F

The relatively short recovery period represents one of UAE’s significant advantages over surgical alternatives.

Risks and Complications of Uterine Artery Embolization

While UAE is generally safe, understanding potential complications helps you make informed treatment decisions.

Common short-term complications:

• Post-embolization syndrome: Cramping, fever, nausea (affects most patients, self-limited)
• Vaginal discharge: As fibroid tissue breaks down and passes
• Infection: Rare but requires antibiotics if it occurs
• Puncture site bruising: Minor bleeding or hematoma

Rare serious complications:

• Premature menopause: Occurs in 1-5% of women, higher risk over age 45
• Fibroid passage: Submucosal fibroids may detach and pass through vagina
• Non-target embolization: Particles inadvertently block blood flow to ovaries
• Allergic reaction: To contrast dye used during imaging
• Hysterectomy requirement: Less than 1% need emergency surgery for complications

Long-term safety considerations:

Clinical evidence demonstrates excellent long-term safety for UAE. The procedure doesn’t increase cancer risk or cause other serious health problems years later. Most complications occur within the first few weeks when they can be promptly addressed. Experienced interventional radiologists minimize risks through precise technique and appropriate patient selection.

When UAE should be avoided:

• Active pelvic infection
• Current pregnancy
• Suspected gynecologic cancer
• Severe contrast dye allergy that cannot be managed
• Significant kidney disease affecting dye clearance

Your interventional radiologist reviews your medical history and imaging to ensure UAE represents an appropriate treatment option for your situation.

UAE and Fertility: What Women Need to Know

The relationship between uterine artery embolization and future pregnancy remains an important consideration for women of reproductive age.

Current evidence on pregnancy after UAE:

Studies demonstrate that pregnancy is possible after UAE, with hundreds of successful pregnancies documented. However, the procedure may affect fertility and pregnancy outcomes. Research comparing UAE to myomectomy shows slightly higher miscarriage rates and pregnancy complications after embolization. The data remains limited since many UAE patients have completed childbearing.

Potential fertility concerns:

• Reduced ovarian reserve from inadvertent particle migration
• Changes in uterine blood flow affecting implantation
• Endometrial thinning in some patients
• Increased miscarriage risk compared to myomectomy
• Higher rates of abnormal placentation

Who should consider myomectomy instead:

Women actively trying to conceive or planning pregnancy within the next year typically choose myomectomy over UAE. This surgical option preserves normal uterine architecture and blood supply more completely. Younger women with significant fertility concerns often opt for myomectomy despite longer recovery. The choice depends on individual priorities and circumstances.

When UAE makes sense despite fertility considerations:

• Severe symptoms requiring rapid treatment
• Multiple prior myomectomies with fibroid recurrence
• High surgical risk from other medical conditions
• Uncertain about future pregnancy plans
• Fibroids in locations making surgical removal difficult

Discussing reproductive goals during consultation ensures you receive treatment aligned with your priorities. Many women successfully become pregnant after UAE, but understanding the nuances helps you make the best decision for your situation.

Who Should Consider Uterine Artery Embolization

Ideal candidates for UAE share specific characteristics that predict favorable outcomes.

Best candidates for UAE:

• Symptomatic fibroids: Heavy bleeding, pelvic pain, or pressure symptoms
• Desire for uterus preservation: Want to avoid hysterectomy
• Completed childbearing: Or no immediate pregnancy plans
• Multiple fibroids: Treat all fibroids simultaneously
• Want faster recovery: Compared to surgical options
• Poor surgical candidates: Medical conditions increasing operative risk

Clinical scenarios favoring UAE:

Women experiencing heavy menstrual bleeding requiring frequent pad or tampon changes benefit significantly from UAE. Those with pelvic pressure causing urinary frequency or constipation see marked improvement. Women whose fibroids cause back pain or discomfort during intercourse typically achieve relief. Patients wanting to avoid general anesthesia and major surgery find UAE particularly appealing.

Pre-procedure evaluation:

Comprehensive assessment ensures UAE suits your situation. Imaging with ultrasound or MRI maps fibroid locations and characteristics. Blood tests check for anemia from chronic bleeding and kidney function for contrast dye safety. Your interventional radiologist reviews medical history, discusses goals, and explains what to expect. This consultation clarifies whether UAE represents the optimal approach for your specific needs.

Dr. Samir Abdel Ghaffar specializes in treating uterine fibroids and adenomyosis through interventional radiology techniques in both London and Cairo. His expertise in catheter-based treatments provides women with effective alternatives to traditional gynecological surgery.

Advances in UAE Technique and Technology

Continued refinements in embolization technique improve outcomes and expand treatment applications.

Modern particle technology:

Earlier UAE procedures used various embolic materials with inconsistent sizing. Current techniques employ precisely calibrated spherical particles that flow predictably through blood vessels. These modern embolic agents lodge specifically in fibroid vasculature while minimizing effects on normal tissue. Research continues exploring optimal particle sizes and materials for different clinical situations.

Imaging improvements:

Advanced fluoroscopy and cone-beam CT provide better visualization during procedures. Three-dimensional imaging helps interventional radiologists identify all vessels feeding fibroids. Real-time feedback ensures complete embolization while avoiding non-target organs. These technological advances contribute to higher success rates and fewer complications.

Technique refinements:

• Selective catheterization reaching smaller vessels
• Radial artery access reducing puncture site complications
• Ovarian artery protection techniques
• Pain management protocols minimizing post-procedure discomfort
• Same-day discharge programs improving patient experience

Future directions:

Researchers explore combining UAE with medications that further shrink fibroids. Studies examine whether targeted drug delivery through catheters enhances outcomes. Investigation continues into identifying biomarkers that predict which patients respond best to embolization. These advances promise to make UAE even more effective for treating symptomatic uterine leiomyomata.

Expert Uterine Artery Embolization in London and Cairo

Uterine artery embolization offers women an effective, minimally invasive alternative to traditional fibroid surgery. This catheter-based technique provides symptom relief while preserving the uterus and allowing rapid recovery. For women struggling with heavy bleeding, pelvic pain, or pressure symptoms from fibroids, UAE represents a valuable treatment option worth serious consideration.

Success with UAE begins with proper patient selection and comprehensive pre-procedure evaluation. Understanding your specific fibroid characteristics, symptoms, reproductive goals, and overall health helps determine whether embolization suits your needs. Working with experienced interventional radiologists ensures optimal technique execution and outcomes.

Dr. Samir Abdel Ghaffar provides specialized interventional radiology care for women with symptomatic uterine fibroids and adenomyosis. His expertise in catheter-based embolization techniques offers patients effective alternatives to hysterectomy and major surgery. With practices in both London and Cairo, Dr. Abdel Ghaffar serves women throughout Europe, the Middle East, and internationally.

Contact Information:

London, UK:

• Clinic: +44 20 8144 2266
• WhatsApp: +44 7377790644

Cairo, Egypt:

• Booking: +20 1000 881336
• WhatsApp: +20 1000 881336

Schedule a consultation to discuss whether uterine artery embolization represents the right treatment approach for your fibroid symptoms. Comprehensive evaluation and personalized care planning ensure you receive treatment aligned with your medical needs and life goals.